Altimmune (ALT) Other Gross PP&E Adjustments (2011 - 2026)
Altimmune (ALT) reported Other Gross PP&E Adjustments of -$1.0 million for Q1 2026, down 123.73% year-over-year from $4.3 million in Q1 2025, and down 449.13% on a QoQ basis from $289000.0 in Q4 2025.
Altimmune (ALT) has 16 years of Other Gross PP&E Adjustments data on file, last reported at -$1.0 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments fell 123.73% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 160.17% YoY) and the FY2025 annual result came in at $289000.0, up 111.37% from the prior year.
- Other Gross PP&E Adjustments declined to -$1.0 million in Q1 2026 per ALT's latest filing, from $289000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $1.1 million in Q1 2022 and bottomed at -$2.5 million in Q4 2024.
- The 5-year median for Other Gross PP&E Adjustments is -$737000.0 (2023), against an average of -$829588.2.
- The widest annual swing landed in 2024, when Other Gross PP&E Adjustments slumped 385.11%; it then soared 111.37% in 2025.
- Tracing ALT's Other Gross PP&E Adjustments over 5 years: stood at -$210000.0 in 2022, then plunged by 149.52% to -$524000.0 in 2023, then sank by 385.11% to -$2.5 million in 2024, then soared by 111.37% to $289000.0 in 2025, then sank by 449.13% to -$1.0 million in 2026.
- Per Business Quant, the three latest ALT Other Gross PP&E Adjustments figures stand at -$1.0 million (Q1 2026), $289000.0 (Q4 2025), and -$403000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | 289,000.00 |
| Dec 31, 2025 | 289,000.00 |
| Sep 30, 2025 | -403,000.00 |
| Sep 30, 2025 | -403,000.00 |
| Jun 30, 2025 | -695,000.00 |
| Jun 30, 2025 | -695,000.00 |
| Mar 31, 2025 | -451,000.00 |
| Mar 31, 2025 | -451,000.00 |
| Dec 31, 2024 | -2.54 Mn |
| Dec 31, 2024 | -2.54 Mn |
| Sep 30, 2024 | -1.99 Mn |
| Sep 30, 2024 | -1.99 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | -605,000.00 |
| Mar 31, 2024 | -605,000.00 |
| Dec 31, 2023 | -524,000.00 |
| Dec 31, 2023 | -524,000.00 |
| Sep 30, 2023 | -737,000.00 |
| Sep 30, 2023 | -737,000.00 |
| Jun 30, 2023 | -747,000.00 |
| Jun 30, 2023 | -747,000.00 |
| Mar 31, 2023 | -840,000.00 |
| Mar 31, 2023 | -840,000.00 |
| Dec 31, 2022 | -210,000.00 |
| Dec 31, 2022 | -210,000.00 |
| Sep 30, 2022 | -1.27 Mn |
| Sep 30, 2022 | -1.27 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Mar 31, 2022 | 1.07 Mn |
| Mar 31, 2022 | 1.07 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 5.80 Mn |
| Sep 30, 2021 | 5.80 Mn |
| Jun 30, 2021 | 5.75 Mn |
| Jun 30, 2021 | 5.75 Mn |
| Mar 31, 2021 | 6.09 Mn |
| Mar 31, 2021 | 6.09 Mn |
| Dec 31, 2020 | 401,712.00 |
| Dec 31, 2020 | 401,712.00 |
| Sep 30, 2020 | -954,394.00 |
| Sep 30, 2020 | -954,394.00 |
| Jun 30, 2020 | -682,670.00 |
| Jun 30, 2020 | -682,670.00 |
| Mar 31, 2020 | -712,278.00 |
| Mar 31, 2020 | -712,278.00 |
| Dec 31, 2019 | 1.13 Mn |
| Dec 31, 2019 | 1.13 Mn |
| Sep 30, 2019 | -728,873.00 |
| Sep 30, 2019 | -728,873.00 |
| Jun 30, 2019 | -762,070.00 |
| Jun 30, 2019 | -762,070.00 |
| Mar 31, 2019 | -789,464.00 |
| Mar 31, 2019 | -789,464.00 |
| Dec 31, 2018 | 1.88 Mn |
| Dec 31, 2018 | 1.88 Mn |
| Sep 30, 2018 | -14,844.00 |
| Sep 30, 2018 | -14,844.00 |
| Jun 30, 2018 | -30,816.00 |
| Jun 30, 2018 | -30,816.00 |
| Mar 31, 2018 | -486,556.00 |
| Mar 31, 2018 | -486,556.00 |
| Dec 31, 2017 | 964,958.00 |
| Dec 31, 2017 | 964,958.00 |
| Sep 30, 2017 | -14,257.00 |
| Sep 30, 2017 | -14,257.00 |
| Jun 30, 2017 | -41,612.00 |
| Jun 30, 2017 | -41,612.00 |
| Dec 31, 2016 | 394,034.00 |
| Dec 31, 2016 | 394,034.00 |
| Dec 31, 2015 | 2.04 Mn |
| Dec 31, 2015 | 2.04 Mn |
| Dec 31, 2014 | 2.51 Mn |
| Dec 31, 2014 | 2.51 Mn |
| Dec 31, 2013 | -928,986.00 |
| Dec 31, 2013 | -928,986.00 |
| Dec 31, 2012 | -658,417.00 |
| Dec 31, 2012 | -658,417.00 |
| Dec 31, 2011 | -210,046.00 |
| Dec 31, 2011 | -210,046.00 |